Teva Pharmaceutical Industries Limited (NYSE:TEVA) down to US$10b market cap, but institutional owners may not be as affected after a year of 7.9% returns - Simply Wall St News
Teva Pharamceutical (NYSE:TEVA) Surges After Earnings Report - TipRanks.com
Is TEVA A Good Stock To Buy? - Insider Monkey
Ex-pharmaceutical company boss faces insider trading charges over Teva deal | The Times of Israel